PE firm invests in growing eClinical solutions company

By Maggie Lynch contact

- Last updated on GMT

(Image: Getty/ Jirupong Manustrong)
(Image: Getty/ Jirupong Manustrong)

Related tags: Private equity, Private equity firm, eclinical, CTMS, Data management, Clinical trials, Clinical research

eClinical technology company, Axiom Real-Time Metrics, will be recapitalized by Great Point Partners to provide eClinical solutions to increase service offerings for Phase I-III clinical trials.

Toronto-based Axiom specializes in electronic data capture (EDC), data management, clinical trial management systems (CTMS), and electronic patient reported outcomes (ePRO) for biotechnology and pharmaceutical sponsors conducting clinical trials.

According to Noah Rhodes, managing director at Great Point Partners, Axiom has been growing at 56% per year over the last six years.

Green Point Partners, which has invested in the clinical trial service industry prior to this recapitalization, approached Axiom regarding the partnership.

While financial details of this recapitalization have not been disclosed, Andrew Schacter, founder and CEO of Axiom said in a statement that, “GPP’s investment will allow Axiom to increase the level of customer service and add additional technology solutions and services.”

Related news

Show more

Related products

show more

What do big pharma companies spend on R&D?

What do big pharma companies spend on R&D?

Zymewire | 15-Aug-2019 | Technical / White Paper

The free Big Pharma R&D Spend report examines the financial performance and research & development investments of the top 25 pharmaceutical companies...

Related suppliers

Follow us

Products

View more

Webinars